Fusion event
HBV-chr22 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
GACACTATTTACACACTCTATGGAAGGCGGGTATATTATATAAGAGAGAAACAACACATAGCGCCTCATTTTGTGGGTCACCATATTCTTGGGAACAAGA| |TCTACAGCATGGGGCAGAATCTTTCCACCAGCAATCCTCTGGGATTCTTTCCCGACCACCAGTTGGATCCAGCCTTCAGAGCAAACACCGCAAATCCAGA
End
30629217/30233228 (Hg38)
Nearest miRNA
hsa-mir-1286/Upstream/226115; hsa-let-7a-3/Downstream/498329;
Upstream sequence
CCTCGGGGGTTCCCTGCTGCTGGGAAGCTGGACCTCCTGTGGGAGGAGTGGGGGAGGGGAGGCAAGCAGAGAATGCGGGAGGCTGAACTGAGTGGGGGGC
Downstream sequence
TCTGGAGGCTGGGGTTGGGGAGACAGAAAGACCCCCCACACATTTCTGTACTTTCTCTGCAGCCTCCAAGAGATCTGGGGTTCCCCTTACTCCATGTGGA
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.